Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Gaining the Competitive Advantage

Posted on June 12th, 2017 by in Pharma R&D

It cannot be overstated how important it is for pharmaceutical companies to get new drugs to market as fast as possible. That some of these drugs could actually be life-saving, or at least life-altering, for hundreds, thousands or even millions of potential patients Continue reading “Gaining the Competitive Advantage” »

FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs

Posted on June 2nd, 2017 by in Pharma R&D

Know the rules

Since 1906, the US Food and Drug Administration (FDA) through regulations has been responsible for ensuring the approval of new drugs whose health benefits outweigh the known risks associated with the drug.

Continue reading “FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs” »

Collaborating to Treat Rare Diseases

Posted on November 16th, 2016 by in Pharma R&D

There are about 7,000 diseases out there that are considered โ€œrare,โ€ but they actually affect hundreds of millions of people worldwide โ€“ nearly half of whom are children. Continue reading “Collaborating to Treat Rare Diseases” »

Molecular Relatives: Prodrugs

Posted on May 19th, 2016 by in Pharma R&D

Iโ€™m an avid sailor, and on our boat we have an amazing device known as a water-maker. It is probably one of the most useful pieces of equipment on board for long cruises, as it takes in sea water, and, through a process of reverse osmosis, provides potable drinking water. Continue reading “Molecular Relatives: Prodrugs” »